Indian pharma companies gear up to fight bird flu

Can Cipla do for bird flu what it has already done for Aids?

Google the words Tamiflu and India on any pharma or life sciences blog and the plans of various Indian pharmaceutical majors Cipla, Ranbaxy, Nicholas Piramal to produce a version of Tamiflu will be among the topics being hotly discussed. Some of the more forthright sites such as www.buytamiflu.org, for example, suggest that, taking star anise to prevent bird flu is not a good idea.

This blog is one of many to be openly supportive of Cipla's stated intention to produce a generic version of a bird flu medicine. What are you going to do about it, Roche, says one blogger Sue Cipla for saving people's lives Protest to the WTO...

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222